RxDoctor Payments Data
★ My doctorsLook up a doctor →

Howard Worman

Hepatology · New York, NYNPI 1649339912

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $110,430 of the $118,652 with a category attached, or 93.1%. Sarepta Therapeutics, Inc. accounts for 99.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $64,152 and has fallen 61.0% since, to $25,001 in 2025.

$118,652in general payments, 2019–2025

Across 66 payments — averaging $1797.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sarepta Therapeutics, Inc.$118K
  • AstraZeneca$760
  • Intra-sana Laboratories$39
$843,167in research payments, 2019–2025

Across 23 payments — averaging $36,659 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sarepta Therapeutics, Inc.$833K
  • Eiger Biopharmaceuticals, Inc.$10K

What the payments were for

  • Consulting fees$110,43093%
  • Travel & lodging$7,6806%
  • Food & beverage$5430%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sarepta Therapeutics, Inc.63$117,853
AstraZeneca1$760
Intra-sana Laboratories2$39

How this compares

$118,652 in reported general payments places this provider in the 75th percentile of 29 hepatology providers in New York.

See all hepatology providers in New York →

Other hepatology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →